Researchers launch RetroChimera model for chemical compound synthesis

Microsoft Research partnered with pharmaceutical firms GSK and Novartis to launch RetroChimera, an AI system trained on drug discovery data. The model demonstrates improved predictions for synthesized molecular structures using proprietary and open research datasets.